Englander Institute for Precision Medicine
Photo credit: EIPM

October 2021

Dear Friend of the Englander Institute for Precision Medicine,

Welcome to our third quarterly newsletter of 2021, we hope you enjoy learning more about the important progress we’ve made since June.

The work of our colleagues in advancing science and speeding new treatments to patients received some really outstanding attention recently (see below) when the story of AML patient Cheryl Bonder was featured on the cover of the WCM Magazine, in a new video, and...

Photo credit: WCM

We are pleased to introduce our newest EIPM Member, Dr. Jason G. Mezey.

Dr. Jason Mezey is a Principal Investigator in the Cornell University Department of Biological Statistics and Computational Biology, and a new Member of the Englander Institute for Precision Medicine.

We hope you enjoy learning more about his research interests and background.

 

Question: Please provide a brief bio and overview of your...

Photo credit: Shutterstock

The master regulator behind the development of antibody-producing cells has been identified in a study by investigators at Weill Cornell Medicine. The findings provide new insight into the inner workings of the immune system and may help understand how tissues develop and how certain cancers arise.

The study, published Sept. 23 in Nature Immunology, combined computational analyses with advanced molecular biology and genomic techniques to identify a protein called Oct2 as the key...